There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alphatec Holdings (ATEC – Research Report), Hologic (HOLX – Research Report) and G1 Therapeutics (GTHX – Research Report) with bullish sentiments.
Alphatec Holdings (ATEC)
In a report released today, David Saxon from Needham reiterated a Buy rating on Alphatec Holdings, with a price target of $18.00. The company’s shares closed last Monday at $14.86.
According to TipRanks.com, Saxon is a 3-star analyst with an average return of
Alphatec Holdings has an analyst consensus of Strong Buy, with a price target consensus of $21.85.
See today’s best-performing stocks on TipRanks >>
Hologic (HOLX)
In a report released today, Michael Matson from Needham maintained a Buy rating on Hologic, with a price target of $83.00. The company’s shares closed last Monday at $72.16.
According to TipRanks.com, Matson is a 1-star analyst with an average return of
Currently, the analyst consensus on Hologic is a Moderate Buy with an average price target of $80.27.
G1 Therapeutics (GTHX)
Needham analyst Gil Blum reiterated a Buy rating on G1 Therapeutics today and set a price target of $14.00. The company’s shares closed last Monday at $3.47.
According to TipRanks.com, Blum is a 1-star analyst with an average return of
G1 Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $9.33, representing a 216.3% upside. In a report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $9.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ATEC:
